Oncoantigens as anti-tumor vaccination targets: The chance of a lucky strike?

Cancer Immunology, Immunotherapy

Volumn 57, Issue 11, 2008, Pages 1685-1694

  Calogero, Raffaele Adolfo ^a   Quaglino, Elena ^a   Saviozzi, Silvia ^a   Forni, Guido ^a   Cavallo, Federica ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Immunotherapy; Tumor antigens; Vaccination

Indexed keywords

AURORA A KINASE; BCL2 INTERACTING KILLER PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN; CD52 ANTIGEN; CELL CYCLE PROTEIN 20; CENTROMERE PROTEIN F; CLAUDIN 3; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; COLLAGEN TYPE 11; CXCL13 CHEMOKINE; CYCLIN B2; DNA TOPOISOMERASE (ATP HYDROLYSING); ENTEROTOXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HEPSIN; LAMININ GAMMA 2; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MATERNAL EMBRYONIC LEUCINE ZIPPER KINASE; MITOGEN ACTIVATED PROTEIN KINASE 13; MLF1 INTERACTING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 2; NEVER IN MITOSIS GENE A RELATED KINASE 2; NUCLEOLAR AND SPINDLE ASSOCIATED PROTEIN 1; PROTEIN REGULATOR OF CYTOKINESIS 1; RHO GTPASE ACTIVATING PROTEIN 8; RIBONUCLEOTIDE REDUCTASE M2 POLYPEPTIDE; SERUM AMYLOID A; SRC KINASE ASSOCIATED PHOSPHOPROTEIN 1; TUMOR ANTIGEN; UNCLASSIFIED DRUG; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ANTIGEN EXPRESSION; BREAST TUMOR; CANCER IMMUNIZATION; CELL MEMBRANE; CELL NUCLEUS; CONFERENCE PAPER; CYTOPLASM; ERBB2 GENE; EXTRACELLULAR SPACE; HUMAN; NEOPLASM; NONHUMAN; ONCOGENE; ONCOGENE NEU; PRIORITY JOURNAL;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECANCEROUS CONDITIONS; RATS; RECEPTOR, ERBB-2; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 50649100672     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-008-0481-x     Document Type: Conference Paper

References (59)

1. L Alinari R Lapalombella L Andritsos RA Baiocchi TS Lin JC Byrd 2007 Alemtuzumab (Campath-1H) in the treatment of chronic lymphocytic leukemia Oncogene 26 3644 3653
2. DC Altieri 2003 Validating survivin as a cancer therapeutic target Nat Rev Cancer 3 46 54
3. A Astolfi L Landuzzi G Nicoletti C De Giovanni S Croci A Palladini S Ferrini M Iezzi P Musiani F Cavallo G Forni P Nanni PL Lollini 2005 Gene expression analysis of immune-mediated arrest of tumorigenesis in a transgenic mouse model of HER-2/neu-positive basal-like mammary carcinoma Am J Pathol 166 1205 1216
4. A Ben-Baruch 2006 The multifaceted roles of chemokines in malignancy Cancer Metastasis Rev 25 357 371
5. K Boggio G Nicoletti E Di Carlo F Cavallo L Landuzzi C Melani M Giovarelli I Rossi P Nanni C De Giovanni P Bouchard S Wolf A Modesti P Musiani PL Lollini MP Colombo G Forni 1998 Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice J Exp Med 188 589 596
6. R Breitling P Armengaud A Amtmann P Herzyk 2004 Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments FEBS Lett 573 83 92
7. RA Calogero F Cordero G Forni F Cavallo 2007 Inflammation and breast cancer. Inflammatory component of mammary carcinogenesis in ErbB2 transgenic mice Breast Cancer Res 9 211
8. F Cavallo A Astolfi M Iezzi F Cordero PL Lollini G Forni R Calogero 2005 An integrated approach of immunogenomics and bioinformatics to identify new tumor associated antigens (TAA) for mammary cancer immunological prevention BMC Bioinformatics 6 Suppl 4 S7
9. F Cavallo RA Calogero G Forni 2007 Are oncoantigens suitable targets for anti-tumour therapy? Nat Rev Cancer 7 707 713
10. F Cavallo R Offringa SH van der Burg G Forni CJ Melief 2006 Vaccination for treatment and prevention of cancer in animal models Adv Immunol 90 175 213
11. FH Chen AO Thomas JT Hecht MB Goldring J Lawler 2005 Cartilage oligomeric matrix protein/thrombospondin 5 supports chondrocyte attachment through interaction with integrins J Biol Chem 280 32655 32661
12. K Chin S DeVries J Fridlyand PT Spellman R Roydasgupta WL Kuo A Lapuk RM Neve Z Qian T Ryder F Chen H Feiler T Tokuyasu C Kingsley S Dairkee Z Meng K Chew D Pinkel A Jain BM Ljung L Esserman DG Albertson FM Waldman JW Gray 2006 Genomic and transcriptional aberrations linked to breast cancer pathophysiologies Cancer Cell 10 529 541
13. WC Cho TT Yip C Yip V Yip V Thulasiraman RK Ngan WH Lau JS Au SC Law WW Cheng VW Ma CK Lim 2004 Identification of serum amyloid a protein as a potentially useful biomarker to monitor relapse of nasopharyngeal cancer by serum proteomic profiling Clin Cancer Res 10 43 52
14. IW Chong MY Chang HC Chang YP Yu CC Sheu JR Tsai JY Hung SH Chou MS Tsai JJ Hwang SR Lin 2006 Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer Oncol Rep 16 981 988
15. C Desmedt F Piette S Loi Y Wang F Lallemand B Haibe-Kains G Viale M Delorenzi Y Zhang MS d'Assignies J Bergh R Lidereau P Ellis AL Harris JG Klijn JA Foekens F Cardoso MJ Piccart M Buyse C Sotiriou 2007 Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series Clin Cancer Res 13 3207 3214
16. T Dohi E Beltrami NR Wall J Plescia DC Altieri 2004 Mitochondrial survivin inhibits apoptosis and promotes tumorigenesis J Clin Invest 114 1117 1127
17. A Domagala M Kurpisz 2001 CD52 antigen-a review Med Sci Monit 7 325 331
18. V Gagarina AL Carlberg L Pereira-Mouries DJ Hall 2008 Cartilage oligomeric matrix protein (COMP) protects cells against death by elevating members of the IAP family of survival proteins J Biol Chem 283 1 648 659
19. D Ghosh 2003 Penalized discriminant methods for the classification of tumors from gene expression data Biometrics 59 992 1000
20. N Giuliani S Bonomini P Romagnani M Lazzaretti F Morandi S Colla S Tagliaferri L Lasagni F Annunziato M Crugnola V Rizzoli 2006 CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival Haematologica 91 1489 1497
21. P Guo Y Imanishi FC Cackowski MJ Jarzynka HQ Tao R Nishikawa T Hirose B Hu SY Cheng 2005 Up-regulation of angiopoietin-2, matrix metalloprotease-2, membrane type 1 metalloprotease, and laminin 5 gamma 2 correlates with the invasiveness of human glioma Am J Pathol 166 877 890
22. O Gutfeld D Prus Z Ackerman S Dishon RP Linke M Levin S Urieli-Shoval 2006 Expression of serum amyloid A, in normal, dysplastic, and neoplastic human colonic mucosa: implication for a role in colonic tumorigenesis J Histochem Cytochem 54 63 73
23. T Hata T Furukawa M Sunamura S Egawa F Motoi N Ohmura T Marumoto H Saya A Horii 2005 RNA interference targeting aurora kinase a suppresses tumor growth and enhances the taxane chemosensitivity in human pancreatic cancer cells Cancer Res 65 2899 2905
24. BA Howard MZ Wang MJ Campa C Corro MC Fitzgerald EF Patz Jr 2003 Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis Proteomics 3 1720 1724
25. AV Ivshina J George O Senko B Mow TC Putti J Smeds T Lindahl Y Pawitan P Hall H Nordgren JE Wong ET Liu J Bergh VA Kuznetsov LD Miller 2006 Genetic reclassification of histologic grade delineates new clinical subtypes of breast cancer Cancer Res 66 10292 10301
26. AE Karnoub AB Dash AP Vo A Sullivan MW Brooks GW Bell AL Richardson K Polyak R Tubo RA Weinberg 2007 Mesenchymal stem cells within tumour stroma promote breast cancer metastasis Nature 449 557 563
27. D Kirchhofer M Peek MT Lipari K Billeci B Fan P Moran 2005 Hepsin activates pro-hepatocyte growth factor and is inhibited by hepatocyte growth factor activator inhibitor-1B (HAI-1B) and HAI-2 FEBS Lett 579 1945 1950
28. SL Kominsky 2006 Claudins: emerging targets for cancer therapy Expert Rev Mol Med 8 1 11
29. SL Kominsky B Tyler J Sosnowski K Brady M Doucet D Nell JG Smedley 3rd B McClane H Brem S Sukumar 2007 Clostridium perfringens enterotoxin as a novel-targeted therapeutic for brain metastasis Cancer Res 67 7977 7982
30. K Koyama K Ito A Hasegawa 2007 Role of male reproductive tract CD52 (mrt-CD52) in reproduction Soc Reprod Fertil Suppl 63 103 110
31. AE Krambeck RH Thompson H Dong CM Lohse ES Park SM Kuntz BC Leibovich ML Blute JC Cheville ED Kwon 2006 B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival Proc Natl Acad Sci USA 103 10391 10396
32. I Kryczek L Zou P Rodriguez G Zhu S Wei P Mottram M Brumlik P Cheng T Curiel L Myers A Lackner X Alvarez A Ochoa L Chen W Zou 2006 B7-H4 expression identifies a novel suppressive macrophage population in human ovarian carcinoma J Exp Med 203 871 881
33. L Lasagni M Francalanci F Annunziato E Lazzeri S Giannini L Cosmi C Sagrinati B Mazzinghi C Orlando E Maggi F Marra S Romagnani M Serio P Romagnani 2003 An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4 J Exp Med 197 1537 1549
34. P Lindberg A Larsson BS Nielsen 2006 Expression of plasminogen activator inhibitor-1, urokinase receptor and laminin gamma-2 chain is an early coordinated event in incipient oral squamous cell carcinoma Int J Cancer 118 2948 2956
35. LA Liotta EC Kohn 2001 The microenvironment of the tumour-host interface Nature 411 375 379
36. PL Lollini F Cavallo P Nanni G Forni 2006 Vaccines for tumour prevention Nat Rev Cancer 6 204 216
37. L Masuelli C Focaccetti V Cereda F Lista D Vitolo P Trono P Gallo A Amici P Monaci M Mattei M Modesti G Forni MH Kraus R Muraro A Modesti R Bei 2007 Gene-specific inhibition of breast carcinoma in BALB-neuT mice by active immunization with rat Neu or human ErbB receptors Int J Oncol 30 381 392
38. LD Miller J Smeds J George VB Vega L Vergara A Ploner Y Pawitan P Hall S Klaar ET Liu J Bergh 2005 An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival Proc Natl Acad Sci USA 102 13550 13555
39. Y Pawitan J Bjohle L Amler AL Borg S Egyhazi P Hall X Han L Holmberg F Huang S Klaar ET Liu L Miller H Nordgren A Ploner K Sandelin PM Shaw J Smeds L Skoog S Wedren J Bergh 2005 Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts Breast Cancer Res 7 R953 R964
40. E Quaglino M Iezzi C Mastini A Amici F Pericle E Di Carlo SM Pupa C De Giovanni M Spadaro C Curcio PL Lollini P Musiani G Forni F Cavallo 2004 Electroporated DNA vaccine clears away multifocal mammary carcinomas in her-2/neu transgenic mice Cancer Res 64 2858 2864
41. E Quaglino S Rolla M Iezzi M Spadaro P Musiani C De Giovanni PL Lollini S Lanzardo G Forni R Sanges S Crispi P De Luca R Calogero F Cavallo 2004 Concordant morphologic and gene expression data show that a vaccine halts HER-2/neu preneoplastic lesions J Clin Invest 113 709 717
42. S Salceda T Tang M Kmet A Munteanu M Ghosh R Macina W Liu G Pilkington J Papkoff 2005 The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation Exp Cell Res 306 128 141
43. W Salz D Eisenberg J Plescia DS Garlick RM Weiss XR Wu TT Sun DC Altieri 2005 A survivin gene signature predicts aggressive tumor behavior Cancer Res 65 3531 3534
44. R Sanges F Cordero RA Calogero 2007 oneChannelGUI: a graphical interface to Bioconductor tools, designed for life scientists who are not familiar with R language Bioinformatics 23 3406 3408
45. B Santiago-Josefat C Esselens JJ Bech-Serra J Arribas 2007 Post-transcriptional up-regulation of ADAM17 upon epidermal growth factor receptor activation and in breast tumors J Biol Chem 282 8325 8331
46. I Simon S Zhuo L Corral EP Diamandis MJ Sarno RL Wolfert NW Kim 2006 B7-h4 is a novel membrane-bound protein and a candidate serum and tissue biomarker for ovarian cancer Cancer Res 66 1570 1575
47. Smyth GK (2004) Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol, Article 1
48. C Sotiriou P Wirapati S Loi A Harris S Fox J Smeds H Nordgren P Farmer V Praz B Haibe-Kains C Desmedt D Larsimont F Cardoso H Peterse D Nuyten M Buyse MJ Van de Vijver J Bergh M Piccart M Delorenzi 2006 Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis J Natl Cancer Inst 98 262 272
49. DM Steel FC Donoghue RM O'Neill CM Uhlar AS Whitehead 1996 Expression and regulation of constitutive and acute phase serum amyloid A mRNAs in hepatic and non-hepatic cell lines Scand J Immunol 44 493 500
50. Y Sun Y Wang J Zhao M Gu R Giscombe AK Lefvert X Wang 2006 B7-H3 and B7-H4 expression in non-small-cell lung cancer Lung Cancer 53 143 151
51. E Tanaka Y Hashimoto T Ito T Okumura T Kan G Watanabe M Imamura J Inazawa Y Shimada 2005 The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma Clin Cancer Res 11 1827 1834
52. I Treilleux JY Blay N Bendriss-Vermare I Ray-Coquard T Bachelot JP Guastalla A Bremond S Goddard JJ Pin C Barthelemy-Dubois S Lebecque 2004 Dendritic cell infiltration and prognosis of early stage breast cancer Clin Cancer Res 10 7466 7474
53. B Tringler S Zhuo G Pilkington KC Torkko M Singh MS Lucia DE Heinz J Papkoff KR Shroyer 2005 B7-h4 is highly expressed in ductal and lobular breast cancer Clin Cancer Res 11 1842 1848
54. G Turashvili J Bouchal K Baumforth W Wei M Dziechciarkova J Ehrmann J Klein E Fridman J Skarda J Srovnal M Hajduch P Murray Z Kolar 2007 Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis BMC Cancer 7 55
55. S Urieli-Shoval RP Linke Y Matzner 2000 Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease states Curr Opin Hematol 7 64 69
56. A Vachani M Nebozhyn S Singhal L Alila E Wakeam R Muschel CA Powell P Gaffney B Singh MS Brose LA Litzky J Kucharczuk LR Kaiser JS Marron MK Showe SM Albelda LC Showe 2007 A 10-gene classifier for distinguishing head and neck squamous cell carcinoma and lung squamous cell carcinoma Clin Cancer Res 13 2905 2915
57. P Westfall A Krishen SS Young 1998 Using prior information to allocate significance levels for multiple endpoints Stat Med 17 2107 2119
58. KS Wilson H Roberts R Leek AL Harris J Geradts 2002 Differential gene expression patterns in HER2/neu-positive and -negative breast cancer cell lines and tissues Am J Pathol 161 1171 1185
59. Q Wu G Parry 2007 Hepsin and prostate cancer Front Biosci 12 5052 5059